Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR072417773

Publication Date:

July 29, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Packaging Machinery [2]

Packaging [3]

Industry & Manufacturing [4]

Description:

The global Passive Temperature Controlled Packaging in Pharma market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Passive Temperature Controlled Packaging in Pharma industry chain, the market status of Pharma Industry (Insulated Boxes, Insulated Containers), Others (Insulated Boxes, Insulated Containers), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Passive Temperature Controlled Packaging in Pharma.
Regionally, the report analyzes the Passive Temperature Controlled Packaging in Pharma markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Passive Temperature Controlled Packaging in Pharma market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Passive Temperature Controlled Packaging in Pharma market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Passive Temperature Controlled Packaging in Pharma industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Insulated Boxes, Insulated Containers).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Passive Temperature Controlled Packaging in Pharma market.
Regional Analysis: The report involves examining the Passive Temperature Controlled Packaging in Pharma market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Passive Temperature Controlled Packaging in Pharma market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Passive Temperature Controlled Packaging in Pharma:
Company Analysis: Report covers individual Passive Temperature Controlled Packaging in Pharma players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Passive Temperature Controlled Packaging in Pharma This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharma Industry, Others).
Technology Analysis: Report covers specific technologies relevant to Passive Temperature Controlled Packaging in Pharma. It assesses the current state, advancements, and potential future developments in Passive Temperature Controlled Packaging in Pharma areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Passive Temperature Controlled Packaging in Pharma market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Passive Temperature Controlled Packaging in Pharma market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Insulated Boxes
Insulated Containers
Other
麻豆原创 segment by Application
Pharma Industry
Others
麻豆原创 segment by players, this report covers
Sonoco ThermoSafe
Hazgo
Cold Chain Technologies
Marken
Jarden Life Sciences
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Passive Temperature Controlled Packaging in Pharma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Passive Temperature Controlled Packaging in Pharma, with revenue, gross margin and global market share of Passive Temperature Controlled Packaging in Pharma from 2019 to 2024.
Chapter 3, the Passive Temperature Controlled Packaging in Pharma competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Passive Temperature Controlled Packaging in Pharma market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Passive Temperature Controlled Packaging in Pharma.
Chapter 13, to describe Passive Temperature Controlled Packaging in Pharma research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Passive Temperature Controlled Packaging in Pharma
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Passive Temperature Controlled Packaging in Pharma by Type
1.3.1 Overview: Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Passive Temperature Controlled Packaging in Pharma Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Insulated Boxes
1.3.4 Insulated Containers
1.3.5 Other
1.4 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 by Application
1.4.1 Overview: Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharma Industry
1.4.3 Others
1.5 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size & Forecast
1.6 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast by Region
1.6.1 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Sonoco ThermoSafe
2.1.1 Sonoco ThermoSafe Details
2.1.2 Sonoco ThermoSafe Major Business
2.1.3 Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Product and Solutions
2.1.4 Sonoco ThermoSafe Passive Temperature Controlled Packaging in Pharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Sonoco ThermoSafe Recent Developments and Future Plans
2.2 Hazgo
2.2.1 Hazgo Details
2.2.2 Hazgo Major Business
2.2.3 Hazgo Passive Temperature Controlled Packaging in Pharma Product and Solutions
2.2.4 Hazgo Passive Temperature Controlled Packaging in Pharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Hazgo Recent Developments and Future Plans
2.3 Cold Chain Technologies
2.3.1 Cold Chain Technologies Details
2.3.2 Cold Chain Technologies Major Business
2.3.3 Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Product and Solutions
2.3.4 Cold Chain Technologies Passive Temperature Controlled Packaging in Pharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Cold Chain Technologies Recent Developments and Future Plans
2.4 Marken
2.4.1 Marken Details
2.4.2 Marken Major Business
2.4.3 Marken Passive Temperature Controlled Packaging in Pharma Product and Solutions
2.4.4 Marken Passive Temperature Controlled Packaging in Pharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Marken Recent Developments and Future Plans
2.5 Jarden Life Sciences
2.5.1 Jarden Life Sciences Details
2.5.2 Jarden Life Sciences Major Business
2.5.3 Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Product and Solutions
2.5.4 Jarden Life Sciences Passive Temperature Controlled Packaging in Pharma Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Jarden Life Sciences Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Passive Temperature Controlled Packaging in Pharma Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Passive Temperature Controlled Packaging in Pharma by Company Revenue
3.2.2 Top 3 Passive Temperature Controlled Packaging in Pharma Players 麻豆原创 Share in 2023
3.2.3 Top 6 Passive Temperature Controlled Packaging in Pharma Players 麻豆原创 Share in 2023
3.3 Passive Temperature Controlled Packaging in Pharma 麻豆原创: Overall Company Footprint Analysis
3.3.1 Passive Temperature Controlled Packaging in Pharma 麻豆原创: Region Footprint
3.3.2 Passive Temperature Controlled Packaging in Pharma 麻豆原创: Company Product Type Footprint
3.3.3 Passive Temperature Controlled Packaging in Pharma 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Passive Temperature Controlled Packaging in Pharma Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Passive Temperature Controlled Packaging in Pharma Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Passive Temperature Controlled Packaging in Pharma 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Passive Temperature Controlled Packaging in Pharma Consumption Value by Type (2019-2030)
6.2 North America Passive Temperature Controlled Packaging in Pharma Consumption Value by Application (2019-2030)
6.3 North America Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Country
6.3.1 North America Passive Temperature Controlled Packaging in Pharma Consumption Value by Country (2019-2030)
6.3.2 United States Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Passive Temperature Controlled Packaging in Pharma Consumption Value by Type (2019-2030)
7.2 Europe Passive Temperature Controlled Packaging in Pharma Consumption Value by Application (2019-2030)
7.3 Europe Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Country
7.3.1 Europe Passive Temperature Controlled Packaging in Pharma Consumption Value by Country (2019-2030)
7.3.2 Germany Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Region
8.3.1 Asia-Pacific Passive Temperature Controlled Packaging in Pharma Consumption Value by Region (2019-2030)
8.3.2 China Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Passive Temperature Controlled Packaging in Pharma Consumption Value by Type (2019-2030)
9.2 South America Passive Temperature Controlled Packaging in Pharma Consumption Value by Application (2019-2030)
9.3 South America Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Country
9.3.1 South America Passive Temperature Controlled Packaging in Pharma Consumption Value by Country (2019-2030)
9.3.2 Brazil Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Passive Temperature Controlled Packaging in Pharma Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Passive Temperature Controlled Packaging in Pharma Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size by Country
10.3.1 Middle East & Africa Passive Temperature Controlled Packaging in Pharma Consumption Value by Country (2019-2030)
10.3.2 Turkey Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Passive Temperature Controlled Packaging in Pharma 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Passive Temperature Controlled Packaging in Pharma 麻豆原创 Drivers
11.2 Passive Temperature Controlled Packaging in Pharma 麻豆原创 Restraints
11.3 Passive Temperature Controlled Packaging in Pharma Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Passive Temperature Controlled Packaging in Pharma Industry Chain
12.2 Passive Temperature Controlled Packaging in Pharma Upstream Analysis
12.3 Passive Temperature Controlled Packaging in Pharma Midstream Analysis
12.4 Passive Temperature Controlled Packaging in Pharma Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Sonoco ThermoSafe
Hazgo
Cold Chain Technologies
Marken
Jarden Life Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.